Frontlight ResearchEarly access
Trial site
Mayo Clinic Cancer Center
- 9running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Pancreatic cancer4 trials
- Colorectal cancer2 trials
- Glioblastoma2 trials
- Melanoma2 trials
- Metastatic breast cancer2 trials
- Childhood cancers1 trial
- Gastric and oesophageal cancer1 trial
- Mesothelioma1 trial
- Prostate cancer1 trial
- Thyroid cancer1 trial
- Phase
- Phase 1/24 trials
- Phase 24 trials
- Phase 12 trials
- Phase 32 trials
- Status
- Recruiting5 trials
- Active, not recruiting4 trials
- Completed3 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- Memorial Sloan Kettering Cancer Center2 trials
- Tango Therapeutics, Inc.2 trials
- ALX Oncology Inc.1 trial
- Cardiff Oncology1 trial
- Dartmouth-Hitchcock Medical Center1 trial
- and 7 more
Running trials
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Active, not recruiting
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Pancreatic cancer3 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Glioblastoma1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026